Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 989K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Voskoboinik, I. Articles by Trapani, J. A. Search for Related Content PubMed PubMed Citation Articles by Voskoboinik, I. Articles by Trapani, J. A. Social Bookmarking                      What's this?

¹ Cancer Immunology Program, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, 3002, Australia
² Rotary Bone Marrow Transplant Unit, The Royal Melbourne Hospital, 3052, Victoria, Australia

Address correspondence to Joseph A. Trapani, Cancer Immunology Program, Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., 8006, Australia. Phone: 61-3-9656-3726; Fax: 61-3-9656-1411; email: joe.trapani{at}petermac.org

About 30% of cases of the autosomal recessive immunodeficiency disorder hemophagocytic lymphohistiocytosis are believed to be caused by inactivating mutations of the perforin gene. We expressed perforin in rat basophil leukemia cells to define the basis of perforin dysfunction associated with two mutations, R225W and G429E, inherited by a compound heterozygote patient. Whereas RBL cells expressing wild-type perforin (67 kD) efficiently killed Jurkat target cells to which they were conjugated, the substitution to tryptophan at position 225 resulted in expression of a truncated (45 kD) form of the protein, complete loss of cytotoxicity, and failure to traffic to rat basophil leukemia secretory granules. By contrast, G429E perforin was correctly processed, stored, and released, but the rat basophil leukemia cells possessed reduced cytotoxicity. The defective function of G429E perforin mapped downstream of exocytosis and was due to its reduced ability to bind lipid membranes in a calcium-dependent manner. This study elucidates the cellular basis for perforin dysfunctions in hemophagocytic lymphohistiocytosis and provides the means for studying structure–function relationships for lymphocyte perforin.

Key Words: HLH • cytotoxic granule • NK cell • CTL • immunodeficiency

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Chia, J., Yeo, K. P., Whisstock, J. C., Dunstone, M. A., Trapani, J. A., Voskoboinik, I. (2009). Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proc. Natl. Acad. Sci. USA 106: 9809-9814 [Abstract] [Full Text]  
• Kuhla, A., Eipel, C., Abshagen, K., Siebert, N., Menger, M. D., Vollmar, B. (2009). Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G1069-G1076 [Abstract] [Full Text]  
• Urrea Moreno, R., Gil, J., Rodriguez-Sainz, C., Cela, E., LaFay, V., Oloizia, B., Herr, A. B., Sumegi, J., Jordan, M. B., Risma, K. A. (2009). Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function. Blood 113: 338-346 [Abstract] [Full Text]  
• Voskoboinik, I., Sutton, V. R., Ciccone, A., House, C. M., Chia, J., Darcy, P. K., Yagita, H., Trapani, J. A. (2007). Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood 110: 1184-1190 [Abstract] [Full Text]  
• Street, S. E.A., Zerafa, N., Iezzi, M., Westwood, J. A., Stagg, J., Musiani, P., Smyth, M. J. (2007). Host Perforin Reduces Tumor Number but Does Not Increase Survival in Oncogene-Driven Mammary Adenocarcinoma. Cancer Res. 67: 5454-5460 [Abstract] [Full Text]  
• Sutton, V. R., Waterhouse, N. J., Browne, K. A., Sedelies, K., Ciccone, A., Anthony, D., Koskinen, A., Mullbacher, A., Trapani, J. A. (2007). Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis. JCB 176: 425-433 [Abstract] [Full Text]  
• Clementi, R., Chiocchetti, A., Cappellano, G., Cerutti, E., Ferretti, M., Orilieri, E., Dianzani, I., Ferrarini, M., Bregni, M., Danesino, C., Bozzi, V., Putti, M. C., Cerutti, F., Cometa, A., Locatelli, F., Maccario, R., Ramenghi, U., Dianzani, U. (2006). Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function. Blood 108: 3079-3084 [Abstract] [Full Text]  
• Baran, K., Ciccone, A., Peters, C., Yagita, H., Bird, P. I., Villadangos, J. A., Trapani, J. A. (2006). Cytotoxic T Lymphocytes from Cathepsin B-deficient Mice Survive Normally in Vitro and in Vivo after Encountering and Killing Target Cells. J. Biol. Chem. 281: 30485-30491 [Abstract] [Full Text]  
• Smyth, M. J., Wallace, M. E., Nutt, S. L., Yagita, H., Godfrey, D. I., Hayakawa, Y. (2005). Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. JEM 201: 1973-1985 [Abstract] [Full Text]  
• Voskoboinik, I., Thia, M.-C., Trapani, J. A. (2005). A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood 105: 4700-4706 [Abstract] [Full Text]  
• Voskoboinik, I., Thia, M.-C., Fletcher, J., Ciccone, A., Browne, K., Smyth, M. J., Trapani, J. A. (2005). Calcium-dependent Plasma Membrane Binding and Cell Lysis by Perforin Are Mediated through Its C2 Domain: A CRITICAL ROLE FOR ASPARTATE RESIDUES 429, 435, 483, AND 485 BUT NOT 491. J. Biol. Chem. 280: 8426-8434 [Abstract] [Full Text]  
• Voskoboinik, I., Thia, M.-C., De Bono, A., Browne, K., Cretney, E., Jackson, J. T., Darcy, P. K., Jane, S. M., Smyth, M. J., Trapani, J. A. (2004). The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. JCB 166: i12-i12 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS